MA-PIERRE-FABRE
Pierre Fabre Pharmaceuticals (Pierre Fabre) and Boston Pharmaceuticals Inc. (Boston Pharmaceuticals) today announced they have entered into a worldwide licensing agreement for Pierre Fabre’s selective potassium channel blocker, F17727.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180104005695/en/
F17727 is a small molecule in late preclinical development for the potential treatment of atrial fibrillation (AF). Under the terms of the agreement, Pierre Fabre grants Boston Pharmaceuticals worldwide exclusive rights for the development, manufacturing and commercialization of F17727. Financial terms of the agreement were not disclosed.
“While our R&D and commercial focus has shifted away from cardiology, we are committed to ensuring that promising compounds are advanced through strategic partnerships to the benefit of patients, ” said Frédéric Duchesne, President & CEO, Pierre Fabre Pharmaceuticals. “Boston Pharmaceuticals’ R&D excellence, collaborative approach and dedication to patients aligns well with our mission and we are pleased to enter this agreement with them for F17727 .”
“This agreement, with such a patient-driven and innovative partner as Pierre Fabre, marks a further significant step in our plan to assemble a diverse portfolio of clinical candidates across a broad range of mechanisms and therapeutic targets. F17727 represents the seventh addition to our rapidly advancing pipeline and our first candidate that addresses cardiovascular disease, ” said Robert Armstrong, Chief Executive Officer of Boston Pharmaceuticals. “We believe F17727 works through a potentially differentiated, highly selective mechanism with the potential to treat atrial fibrillation and look forward to advancing this candidate to further evaluate its potential.”
For more information, please visit www.pierre-fabre.com
For more information, please visit www.bostonpharmaceuticals.com .
View source version on businesswire.com: http://www.businesswire.com/news/home/20180104005695/en/
Contact:
Pierre Fabre
Valérie Roucoules, (33) 1 49 10 83 84
valerie.roucoules@pierre-fabre.com
or
Boston
Pharmaceuticals
Kari Watson, (781) 235 3060
MacDougall
Biomedical Communications
kwatson@macbiocom.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting udvider sine kompetencer inden for humankapital med HAGER Executive Consulting10.9.2025 21:08:00 CEST | Pressemeddelelse
Andersen Consulting styrker sit udbud inden for humankapital via en samarbejdsaftale med HAGER Executive Consulting – et firma, der specialiserer sig i bestyrelsesservices, executive search og ledelsesudvikling. HAGER blev grundlagt i 1996 og hjælper kunder internationalt på tværs af brancher – herunder industri, sundhedssektoren og finansielle tjenester – gennem executive search-tjenester og governance-løsninger. Firmaets tilgang integrerer dybdegående sektorindsigt med en unik metode, der fokuserer på at matche ledelsespotentiale med forretningsmæssig transformation. "Executive search handler om mere end bare at finde en person til en stilling; det handler om at genkende potentiale og opbygge lederskab, der varer ved," sagde Martin Krill, der er managing partner hos HAGER. "Vores tjenester fokuserer på at forbinde formålsdrevede ledere med organisationer, der er klar til forandring. Gennem samarbejdet med Andersen Consulting forstærker vi denne mission på globalt plan." "HAGER har sk
Riyadh to Host the First Edition of BIO Middle East10.9.2025 20:01:00 CEST | Press release
The Saudi Ministry of Health has announced the launch of the first edition of BIO Middle East, the region’s pioneering event dedicated entirely to biotechnology. The event will take place from May 11 to 13, 2026, co-locating with CPHI Middle East at the Riyadh Exhibition and Convention Centre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250910348484/en/ Riyadh to Host the First Edition of BIO Middle East (Graphic: AETOSWire) A first of its kind for the region, the event reinforces the Kingdom’s leadership in this fast-growing sector and underscores its commitment to becoming a regional and global hub for pharmaceuticals and life sciences. As part of a global series of landmark BIO gatherings that bring together leaders, innovators, and investors from across the world, BIO Middle East will extend this world-class platform for partnership and innovation to the region for the very first time. The BIO Middle East exhibition a
SingleStore Announces Growth Buyout Led by Vector Capital10.9.2025 19:00:00 CEST | Press release
Accelerates growth strategy to capture the expanding global opportunity in enterprise AI under Vector’s majority ownership SingleStore, Inc. (“SingleStore” or the “Company”), the leading data platform for enterprise AI, today announced it has entered into an agreement with Vector Capital Management, L.P. (“Vector”), a private equity firm with a nearly three decade track record leading transformational investments in established technology businesses, in which Vector will lead a growth buyout of SingleStore. Raj Verma, SingleStore’s Chief Executive Officer, and the Company’s established management team, who together have decades of experience in leading fast-growth, AI-first enterprise technology companies, will continue to lead the business. Long-term SingleStore shareholders including Google Ventures, Dell Technologies Capital, IBM, and REV Venture Partners will remain as investors in SingleStore. Several Vector Capital limited partners such as Adams Street Partners, J.P. Morgan Asset
FIA President Mohammed Ben Sulayem Leads Fight Against Online Abuse, Bringing Global Leaders Together in Stockholm10.9.2025 18:22:00 CEST | Press release
The second annual United Against Online Abuse global conference took place in Stockholm, Sweden, bringing together global and industry leaders in-person and onlineKey speakers included representatives from TikTok, The FIA, and Signify Group, highlighting the importance of protecting the sporting community from digital harm The Fédération Internationale de l'Automobile (FIA), the global governing body for motorsport and the federation for mobility organisations worldwide, has welcomed industry experts and thought leaders to Stockholm, Sweden, for the second global United Against Online Abuse (UAOA) conference. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250910299906/en/ FIA President and UAOA Founder, Mohammed Ben Sulayem, speaking at the second global United Against Online Abuse (UAOA) conference. Bringing together voices from the world of sport, politics, and social media, the coalition reaffirmed their collective commit
Verimatrix and Velocix Team Up to Fight CDN Piracy10.9.2025 17:45:00 CEST | Press release
Combined client and server-side tech stops CDN leeching and reduces delivery costs Regulatory News: Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced a strategic collaboration with Velocix, the market’s premier carrier-grade CDN software provider, to help streaming providers combat piracy, boost paid video subscriptions, and cut CDN costs. This joint initiative provides streaming providers with the means to detect, deny, and prevent unsanctioned usage of CDN capacity by third parties. CDN leeching, where unauthorized users consume content directly from the network without paying for it, is a critical and costly challenge for video service providers. Verimatrix Streamkeeper™ Counterspy protects the client side, ensuring only legitimate users can access content, by providing string app authentication, protecting content keys, and safeguarding the token exchange. Velocix’s Carrier-Grade CDN and Video Analyti
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom